25C-NB3OMe Stats & Data

• Potent sub‑milligram psychedelic; overdose risk is elevated because small measurement errors can equal many active doses. Use volumetric dosing rather than attempting to weigh powder; a 0.001 g scale is not adequate for single‑dose measurement. Keep clearly labeled solutions and avoid ‘drops to tongue’.

• NBOMe-class compounds (including NB3OMe analogues) are commonly taken buccally/sublingually or intranasally; swallowing alone often yields little or delayed effect due to first‑pass metabolism. Allergy test 50–100 µg buccal, then wait at least 2 h before any increase.

• Insufflation accelerates onset but increases risks of hypertension, severe vasoconstriction, agitation, seizures, and unpredictable behavior; several NBOMe emergencies follow intranasal overdosing. Avoid re‑dosing during the come‑up.

• Mis‑sold LSD risk: NBOMes have frequently appeared on blotter; LSD is usually tasteless while NBOMes are often distinctly bitter and cause local oral numbness. Always test suspected ‘LSD’ with an Ehrlich reagent (LSD turns purple; NBOMes do not). TLC/GC‑MS drug checking is ideal.

• Physiological risks to watch for include marked peripheral vasoconstriction (cold, tingling, blue fingers/toes), tachycardia, hypertension, hyperthermia, and—at high doses—confusion/delirium and seizures. If chest pain, severe confusion, or blue/numb extremities persist, seek urgent medical care and state that an NBOMe‑type psychedelic may be involved; do not drive.

• Manage vasoconstriction conservatively: keep warm, avoid nicotine/other stimulants, hydrate with electrolytes, rest; do not attempt to self‑medicate BP with random drugs. Agitation or panic is typically managed with quiet environment and, if available and appropriate, a known benzodiazepine ‘rescue’ dose—avoid alcohol.

• Set/setting: have a trusted sober sitter, especially for first trials. Avoid strenuous activity and hot environments due to hyperthermia risk. Insomnia after-effects are common; plan 24–48 h before resuming driving or safety‑critical tasks.

• Cross‑tolerance with classic psychedelics is expected; leave 10–14 days between strong sessions to reduce tolerance and compulsive redosing pressure.

• Oral/buccal potency and blotter loading can vary widely between batches for this class; start low each new source.

• Avoid combining with serotonergic poly‑drug stacks (e.g., MDMA plus stimulants) given seizure and hyperthermia reports in the NBOMe class.